Back to Search Start Over

Relapse Incidence Post Unrelated Allogeneic Stem Cell Transplantation with Post-Transplant Cyclophosphamide (PTCy) in Patients with Acute Myeloid Leukemia: A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Authors :
Nagler, Arnon
Ngoya, Maud
Galimard, Jacques-Emmanuel
Labopin, Myriam
Blau, Wolfgang-Igor
Kroger, Nicolaus
Gedde-Dahl, Tobias
Schroeder, Thomas
Burns, David
Salmenniemi, Urpu
Rambaldi, Alessandro
Choi, Goda
de Latour, Régis Peffault
Vydra, Jan
Sengeloev, Henrik
Eder, Matthias
Mielke, Stephan
Forcade, Edouard
Bondarenko, Sergey N.
Ciceri, Fabio
Mohty, Mohamad
Source :
Transplantation and Cellular Therapy; February 2024, Vol. 30 Issue: 2, Number 2 Supplement 1 pS46-S47, 2p
Publication Year :
2024

Abstract

Post-transplant cyclophosphamide (PTCy) reduces chronic (c) graft-versus-host disease (GVHD) and thus may suppresses the graft-versus-leukemia (GVL) effect leading to increased relapse (RI).

Details

Language :
English
ISSN :
26666375 and 26666367
Volume :
30
Issue :
2, Number 2 Supplement 1
Database :
Supplemental Index
Journal :
Transplantation and Cellular Therapy
Publication Type :
Periodical
Accession number :
ejs65462647
Full Text :
https://doi.org/10.1016/j.jtct.2023.12.080